Charleston, SC -- (SBWIRE) -- 10/04/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Biozone Pharmaceuticals Inc (OTCBB:BZNE), STELLAR BIOTECH INC (OTCMKTS:SBOTF), Buka Ventures Inc (OTCBB:NNRX), OncoSec Medical Inc (OTCMKTS:ONCS)
Biozone Pharmaceuticals Inc (OTCBB:BZNE) decreased -5.56% and closed at $0.510 on a traded volume of 4.83 million shares, in comparison to 652,668 shares of average trading volume. So far this year, the stock is down over -83.00%.
The company has a total market capitalization of $35.50 million and its total outstanding shares are 69.61 million. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally.
Has BZNE Found The Bottom And Ready To Gain Momentum? Find Out Here
STELLAR BIOTECH INC (OTCMKTS:SBOTF) plunged -7.48% and closed at $1.36 on a traded volume of 665,043 shares, whereas its average trading volume is 469,748 shares. In the last three months, the stock is up +89.68%. The Intra-day range for the stock is $1.25 and $1.48.
Stellar Biotechnologies, Inc. produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and subunit KLH formulations in the United States and Europe.
Why Should Investors Buy SBOTF After the Recent Fall? Just Go Here and Find Out
Buka Ventures Inc (OTCBB:NNRX) dropped down -14.58% and closed at $0.410. So far in three months, the stock is down -45.33%. The 52-week range for the stock is $0.12 and $1.48 and during the previous trading session the stock touched its highest price at $0.55. Its introductory price for the day was $0.50, with the overall traded volume of 1.61 million shares.
Will NNRX Get Buyers Even After The Recent Rally? Find Out Here
OncoSec Medical Inc (OTCMKTS:ONCS), after opening its shares at the price of $0.28, jumped up +0.92% to close at $0.275 for the day. The stock moved on a traded volume of 3.15 million shares, in comparison to 2.47 million shares of average trading volume.
The 52-week range for the stock is $0.18 and $0.49 and during the previous trading session the stock touched its highest price at $0.28. Its introductory price for the day was $0.28. OncoSec Medical Incorporated, a drug-medical device and therapeutic company, designs, develops, and commercializes medical approaches for the treatment of solid tumors in the United States.
For How Long ONCS’s Gloss will Attract Investors? Find out via this report
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)